MARSHALL WACE, LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$439,123
-61.2%
114,355
-49.9%
0.00%
-66.7%
Q4 2022$1,132,938
+0.3%
228,415
-3.3%
0.00%
+50.0%
Q3 2022$1,129,000
-73.4%
236,200
-54.8%
0.00%
-89.5%
Q1 2021$4,237,000
+609.7%
523,087
+199.0%
0.02%
+216.7%
Q1 2020$597,000
+2.6%
174,919
+53.5%
0.01%
+50.0%
Q4 2019$582,000
+85.4%
113,932
-21.2%
0.00%
+33.3%
Q2 2019$314,000
-75.0%
144,493
-44.8%
0.00%
-76.9%
Q4 2018$1,256,000261,6080.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2019
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders